Dr Vall is a board-certified clinical laboratory scientist (CLS) and holds a Qualification in Cytometry (QCYM) certification from the American Society for Clinical Pathology. He received his doctorate at the National University of Rosario, Argentina. Prior to joining Integrated Oncology (formerly US LABS), a member of the Labcorp Specialty Testing Group, Dr Vall served for 3 years as vice president of laboratory services at Clarient, Inc., where he was responsible for developing and implementing specific tests on flow cytometry, molecular oncology, and FISH using conventional and new ways to improve laboratory’s efficiencies and work flow. Prior to that, Dr Vall worked for Genzyme (formerly Impath) for 8 years, where, as the corporate technical director for high complexity testing, he was responsible for new technologies involving flow cytometry, image analysis, and complex molecular-based testing. He was also responsible for the overall management of all clinical laboratory testing, operations, and test development for the division, and led the QA & QC team in assessment and development of the product pipeline and technology utilization.
During the early 1990s, Dr Vall worked on leukemia-lymphoma flow cytometry analysis and helper/suppressor studies in transplant patient for drug monitoring, conducted studies on immunodeficiency patients using flow cytometry, and performed stem cell studies for autologous bone marrow transplants at both Loma Linda University Medical Center and City of Hope National Medical Center.
Dr Vall is a member of the Clinical Cytometry Society and the Rheumatoid Society.